Items tagged with Public health

Global pharmaceutical industry calls on governments to work with them to beat the rising threat of antimicrobial resistance (post with simple image)

In a joint declaration more than 80 leading international pharmaceutical, generics, diagnostics and biotechnology companies, as well as key industry bodies, call on governments and industry to work in parallel in taking comprehensive action against antimicrobial resistance.

As U.N. General Assembly starts, MSF urges governments to set medical research policies that align with people’s health needs (post with simple image)

New MSF report exposes pharma industry failings and highlights new ways of researching and developing medicines that address public health needs.

U.N. High-Level Panel on Access to Medicines releases final report (post with simple image)

United Nations Secretary-General’s High-Level Panel on Access to Medicines calls for new deal to close the health innovation and access gap.

At U.N., global leaders commit to act on antimicrobial resistance (post with simple image)

World leaders signal an unprecedented level of attention to curb the spread of infections that are resistant to antimicrobial medicines.

December 2016 issue of Public Health Action now online (post with simple image)

Public Health Action is the free access, online journal of The International Union Against Tuberculosis and Lung Disease. The journal focuses on tuberculosis, lung health, non-communicable diseases and related public health issues.

Mark Dybul: Megatrends and maximizing impact (post with simple image)

On 31 May, Mark Dybul completed a four-year term as Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria. The following is adapted from remarks he recently made to the Global Fund Board.

Enter the African Medicines Agency, continent’s first super-regulator? (post with simple image)

An African Medicines Agency, the continent’s first super-regulator, could be approved as soon as next year.

Access to medicines for all by 2030: New WHO strategic framework sets vision (post with simple image)

Access to affordable and quality medicines for all is one of the major commitments of the World Health Organization, and its new medicines and health products strategic framework for the next 15 years calls for new research and development (R&D) models, including delinkage of the R&D costs from the price of products, and fair pricing.

Page 15 of 15 · Total posts: 0

←First 14 15